Methodological issues in assessing changes in costs pre- and post-medication switch: a schizophrenia study example
Open Access
- 1 January 2009
- journal article
- Published by Springer Science and Business Media LLC in Cost Effectiveness and Resource Allocation
- Vol. 7 (1), 11-7
- https://doi.org/10.1186/1478-7547-7-11
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Effectiveness of Switching Antipsychotic MedicationsAmerican Journal of Psychiatry, 2006
- Clinical Trial-Based Cost-Effectiveness Analyses of Antipsychotic UseAmerican Journal of Psychiatry, 2006
- Switching to olanzapine after unsuccessful treatment with risperidone during the first episode of schizophrenia: an open-label trial.2006
- Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophreniaBMC Psychiatry, 2006
- Effectiveness of Antipsychotic Drugs in Patients with Chronic SchizophreniaNew England Journal of Medicine, 2005
- Effect of switching antipsychotics on antiparkinsonian medication use in schizophreniaThe British Journal of Psychiatry, 2005
- Cost analysis of treating schizophrenia with amisulpride: Naturalistic mirror image studyProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2005
- Do new prescription drugs pay for themselves?: The case of second-generation antipsychoticsJournal of Health Economics, 2005
- Economic outcomes associated with switching individuals with schizophrenia between risperidone and olanzapine: findings from a large US claims database.2004
- Economic evaluations of novel antipsychotic medications: a literature reviewSchizophrenia Research, 2002